Michigan Medicine's Health Lab's Lab Report shared new findings from the NeuroNetwork for Emerging therapies that certain blood lipid profiles can predict the risk of nerve damage 10 years later in patients with type 2 diabetes.
U.S. News & World Report covered important new findings by Dr. Stephen Goutman about which occupations increase ALS risk.
The NeuroNetwork for Emerging Therapies, led by primary investigators Eva Feldman, M.D., Ph.D., and Junghuk Hur, Ph.D., M.S., will look at dietary interventions and the mechanisms underlying their benefits with a new R01 grant from the National Institute of Diabetes and Digestive and Kidney Diseases.
On site of the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) this morning, Brian Callaghan, M.D., M.S., shared via video a few key points from the talk he had just finished that shared the new American Academy of Neurology (ANN) Painful Diabetic Neuropathy guidelines.
Michigan Medicine's Health Lab's Lab Report shared a recent study by Stephen Goutman, M.D., that found that ALS risk is higher among production workers, those exposed to metals, and volatile compounds on the job due to Michigan's legacy industry and agriculture.
Portraits of Drs. Eva Feldman and Stephen Goutman, directors of the ALS Center of Excellence and Pranger ALS Clinic respectively, take center stage in newly launched visuals on the research page of the National ALS Registry, part of the Agency for Toxic Substances and Disease Registry (ATSDR) at the Centers for Disease Control and Prevention
